These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31061182)

  • 21. Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit.
    Zhao H; Coote S; Pesavento L; Jones B; Rodrigues E; Ng JL; Ng F; Yan B; Parsons M; Campbell BC; Easton D; Donnan GA; Davis SM
    Int J Stroke; 2019 Apr; 14(3):265-269. PubMed ID: 30014785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
    Lin YT; Lai YJ; Lai TH
    J Emerg Med; 2020 Mar; 58(3):e113-e116. PubMed ID: 31744711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
    Kermer P; Eschenfelder CC; Diener HC; Grond M; Abdalla Y; Althaus K; Berrouschot J; Cangür H; Daffertshofer M; Edelbusch S; Gröschel K; Haase CG; Harloff A; Held V; Kauert A; Kraft P; Lenz A; Müllges W; Obermann M; Partowi S; Purrucker J; Ringleb PA; Röther J; Rossi R; Schäfer N; Schneider A; Schuppner R; Seitz RJ; Szabo K; Wruck R
    Int J Stroke; 2017 Jun; 12(4):383-391. PubMed ID: 28494694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J; Waters MJ; Drew R; Fink JN; Wilson D; Campbell BCV; Parsons MW; Kleinig TJ; Wu TY
    Stroke; 2020 May; 51(5):1616-1619. PubMed ID: 32208845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
    Kermer P; Eschenfelder CC; Diener HC; Grond M; Abdalla Y; Abraham A; Althaus K; Becks G; Berrouschot J; Berthel J; Bode FJ; Burghaus L; Cangür H; Daffertshofer M; Edelbusch S; Eggers J; Gerlach R; Gröschel K; Große-Dresselhaus F; Günther A; Haase CG; Haensch CA; Harloff A; Heckmann JG; Held V; Hieber M; Kauert A; Kern R; Kerz T; Köhrmann M; Kraft P; Kühnlein P; Latta J; Leinisch E; Lenz A; Leithner C; Neumann-Haefelin T; Mäurer M; Müllges W; Nolte CH; Obermann M; Partowi S; Patzschke P; Poli S; Pulkowski U; Purrucker J; Rehfeldt T; Ringleb PA; Röther J; Rossi R; El-Sabassy H; Sauer O; Schackert G; Schäfer N; Schellinger PD; Schneider A; Schuppner R; Schwab S; Schwarte O; Seitz RJ; Senger S; Shah YP; Sindern E; Sparenberg P; Steiner T; Szabo K; Urbanek C; Sarnowksi BV; Weissenborn K; Wienecke P; Witt K; Wruck R; Wunderlich S
    Int J Stroke; 2020 Aug; 15(6):609-618. PubMed ID: 31955706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.
    Hieber M; Hollasch H; Heck D; Mächtel M; Geisen U; Niesen WD; Brich J; Harloff A
    J Thromb Thrombolysis; 2018 Jul; 46(1):12-15. PubMed ID: 29633066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebellar vermis: a vulnerable location of remote brain haemorrhages after thrombolysis for ischaemic stroke.
    Tejada-Meza H; Modrego PJ
    Neurol Sci; 2017 Jan; 38(1):185-187. PubMed ID: 27709302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis.
    Romoli M; Matteo E; Migliaccio L; Gentile M; Mosconi MG; Scura GM; Naccarato M; Colangeli E; Candelaresi P; Andreone V; Giammello F; Fortunata Musolino R; Dell'Aera C; Sepe FN; Pronello E; Barbarini L; Caggiula M; Rizzo F; Petruzzellis M; Giorli E; Zedde ML; Anticoli S; Mangiardi M; Muto M; Diana F; De Angelis MV; Digiovanni A; Concari L; La Gioia S; Sessa M; Biguzzi S; Cordici F; Longoni M; Ruggiero M; Cenciarelli S; Eusebi P; Sacco S; Caso V; Paciaroni M; Ricci S; Zini A; Toni D; Giannandrea D
    Eur Stroke J; 2023 Mar; 8(1):117-124. PubMed ID: 37021155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?
    Ting A; Venkat AR; Gawarikar Y; Patel R
    Med J Aust; 2019 Apr; 210(7):302-303.e1. PubMed ID: 30924530
    [No Abstract]   [Full Text] [Related]  

  • 30. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.
    Pikija S; Sztriha LK; Sebastian Mutzenbach J; Golaszewski SM; Sellner J
    CNS Drugs; 2017 Sep; 31(9):747-757. PubMed ID: 28808918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [First case of thrombolysis with non-immunogenic staphylokinase in a patient with ischemic stroke receiving dabigatran etexilate followed by thrombectomy].
    Ramazanov GR; Kokov LS; Shamalov NA; Kovaleva EA; Klychnikova EV; Akhmatkhanova LK; Cheboksarov DV; Khamidova LT; Muslimov RS; Rybalko NV; Petrikov SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):145-151. PubMed ID: 35758961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients.
    Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
    CNS Drugs; 2021 Feb; 35(2):233-242. PubMed ID: 33548038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of the Anticoagulation Effects of Dabigatran Etexilate by Idarucizumab in Three Patients Needing Urgent Surgical Intervention and One Case of Intravenous Thrombolysis in Ischaemic Stroke.
    von Wowern F; Brizzi M; Holst J
    Eur J Case Rep Intern Med; 2017; 4(4):000569. PubMed ID: 30755937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful dabigatran reversal after subdural hemorrhage using idarucizumab in a mobile stroke unit: A case report.
    Thirunavukkarasu S; Kalashyan H; Jickling G; Jeerakathil TJ; Jayaprakash HK; Buck BH; Shuaib A; Butcher K
    Medicine (Baltimore); 2020 May; 99(21):e20200. PubMed ID: 32481289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment with idarucizumab for diffuse alveolar hemorrhage induced by dabigatran etexilate: a case report.
    Shiroshita A; Nakashima K; Tanaka Y; Tateishi A; Nemoto M; Aoshima M
    J Thromb Thrombolysis; 2018 Aug; 46(2):271-273. PubMed ID: 29740732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases.
    Vosko MR; Bocksrucker C; Drwiła R; Dulíček P; Hauer T; Mutzenbach J; Schlimp CJ; Špinler D; Wolf T; Zugwitz D
    J Thromb Thrombolysis; 2017 Apr; 43(3):306-317. PubMed ID: 28210988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idarucizumab-facilitated intravenous thrombolysis in acute ischemic stroke: A therapeutic strategy requiring further investigation.
    Hsiao YJ; Tsai YT; Tsai LK; Fang CW
    J Neurol Sci; 2018 Nov; 394():144-145. PubMed ID: 30266415
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.
    Cappellari M; Forlivesi S; Squintani GM; Facchinetti R; Bovi P
    J Thromb Thrombolysis; 2017 May; 43(4):528-529. PubMed ID: 28214949
    [No Abstract]   [Full Text] [Related]  

  • 39. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy.
    Kikule I; Baborikina A; Haritoncenko I; Karelis G
    Medicina (Kaunas); 2022 Sep; 58(10):. PubMed ID: 36295516
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Alvarez Bravo G; Orts Castro E; Carvalho Monteiro G; López Zuazo I
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.